News
Minimal specimen requirements make it suitable for a wide range of tumor types and practice settings. The assay builds on the company’s tissue-based CGP platform, previously known as NeoComprehensive ...
Imagine that you want to know the plot of a movie, but you only have access to either the visuals or the sound. With visuals ...
2d
News-Medical.Net on MSNAdvanced imaging techniques uncover new roles for CD8+ T cells in tissue regenerationAdvanced imaging technologies are uncovering surprising roles for CD8+ T cells—not just in immune defense, but also in supporting tissue repair and regeneration.
21h
Stockhead on MSNHealth Check: Promedicus shares smash record $300 barrier on back of mega dealsShares in radiology imaging giant Promedicus today soared almost 10% on two client wins worth $190 million in revenue.
New DNA test predicts chemotherapy resistance before treatment, potentially sparing patients from ineffective toxic drugs.
2don MSN
A study published in mBio details the vulnerability of coronaviruses to inhibitors of a small protein domain called Mac1, or the "macrodomain," found in all coronaviruses such as SARS-CoV-2 and ...
In a bold move that could reshape the future of biomedical research, Boster Bio is launching a Free Antibody Validation ...
SOUTH SAN FRANCISCO, Calif., June 27, 2025 (GLOBE NEWSWIRE) -- Pliant Therapeutics, Inc. (Nasdaq: PLRX) today announced that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results